Phase I Clinical Trial with LBH589 and Infusional 5-FU/LV in Patients with Metastatic Colorectal Cancer who Failed 5-FU Based Chemotherapy.

Trial Profile

Phase I Clinical Trial with LBH589 and Infusional 5-FU/LV in Patients with Metastatic Colorectal Cancer who Failed 5-FU Based Chemotherapy.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2015

At a glance

  • Drugs Panobinostat (Primary) ; Fluorouracil; Folinic acid
  • Indications Colorectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Apr 2014 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
    • 24 Apr 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov record.
    • 29 Jan 2014 Planned End Date changed from 1 Jun 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top